1804
L. Knerr, R. R. Schmidt
LETTER
Lett. 1996, 37, 6985. (b) Shimizu, H.; Ito, Y.; Kanie, O.;
Ogawa, T. Bioorg. Med. Chem. Lett. 1996, 6, 2841.
(c) Fukase, K.; Nakai, Y.; Egusa, K.; Porco, Jr., J. A.;
Kusumoto, S. Synlett, 1999, 1074.
(15) Protocol for RCM mediated cleavage: resin 12 (0.04 mmol)
was swollen in 10 ml of dry CH2Cl2. The resulting suspension
was degassed for 30 min using a steam of argon. 1 (3 mg, 3.6
mmol, 9 mol%) was then added and the mixture was shaken for
6h at r.t. under argon. The reaction solvent was collected and
the resin was washed three times each with 5 ml of THF and 5
ml of CH2Cl2. The combined filtrates were evaporated. The
resin was dried for 18h under high vacuum and submitted a
second time to the cleavage conditions. The combined filtrates
of both cleavage reactions were then submitted to silica gel
column chromatography to afford 37 mg of 13 (51% from 7).
(16) Protocol for Maldi-TOF analytical cleavage: 4 mg of resin
12 in 500 ml of dry CH2Cl2 were degassed. A few crystals of 1
were added to this suspension. The mixture was stirred for 4h
at r.t.. Satisfactory TLCs are obtained from the crude reaction.
The catalyst was then filtered over a small pad of silica gel
(0.4*1cm) and the cleaved compounds were eluted with ethyl
acetate (10 ml). The solvents were then evaporated and the
resulting crude was analyzed by Maldi-TOF in the usual way.
(17) Analytical data of compound 13:
(5) Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H. Angew.
Chem. 1995, 107, 2179; Angew. Chem. Int. Ed. Engl. 1995,
34, 2039.
(6) For recent general reviews on the metathesis reaction see:
(a) Chang, S.; Grubbs, R. H. Tetrahedron 1998, 54, 4413.
(b) Schuster, M.; Blechert, S. Angew. Chem., 1997, 109, 2124;
Angew. Chem. Int. Ed. Engl. 1997, 36, 2036.
(7) For reviews on applications of ring closing metathesis see:
(a) Armstrong, S. K. J. Chem. Soc., Perkin Trans. 1 1998, 371.
(b) Schmalz, H. G. Angew. Chem. 1995, 107, 1981; Angew.
Chem. Int. Ed. 1995, 34, 1833.
(8) For some recent RCM mediated cyclization/cleavage
strategies leading to cyclic alkenes see: (a) Nicolaou, K. C.;
Winssinger, N.; Pastor, J.; Ninkovic, S.; Sarabia, F.; He, Y.;
Vourloumis, D.; Li, T.; Giannakakou, P.; Hamel, E. Nature
1997, 387, 268. (b) Pernerstorfer, J.; Schuster, M.; Blechert, S.
J. Chem. Soc., Chem. Commun. 1997, 1949. (c) Veerman, J. J.
N.; van Maarseveen, J. H.; Visser, G. M.; Kruse, C. G.;
Schoemaker, H. E.; Hiemstra, H.; Rutjes, F. P. J. T. Eur. J.
Org. Chem. 1998, 2583. (d) Piscopio, A. D.; Miller, J. F.;
Koch, K. Tetrahedron 1999, 55, 8189.
MALDI-TOF (DHB/THF), calcd: M(C107H106O26) = 1808.02
m/z; (M+Na)+ = 1831.02 m/z. Found: 1830 m/z.
13b: 1H NMR (600 MHz, CDCl3): d 1.53 [C(CH3)2], 3.06 (5a-
H), 3.20 (6b-H), 3.23 (5b-H), 3.27 (2a-H), 3.32 (3a-H), 3.34
(6b-H'), 3.42 (6a-H), 3.46 (2b-H), 3.51 (6d-H), 3.52 (6a-H'),
3.53 (3b-H), 3.70 (5d-H), 3.71 (5c-H), 3.76 (4a-H), 3.77 (4b-
H), 3.99 [CHHCH=CH2], 4.00 (4d-H), 4.02-4.92 [6CH2Ph],
4.13 (4c-H), 4.16 (6d-H'), 4.18 (3d-H), 4.21 (1b-H), 4.24 (1a-
H, J1,2 = 8Hz), 4.27 [CHHCH=CH2], 4.40 (6c-H), 4.54 (1d-H),
4.62 (6d-H'), 5.02 (1c-H), 5.08 (2d-H), 5.09 [CH2CH=CHH],
5.23 [CH2CH=CHH], 5.47 (2c-H), 5.67 (3c-H), 5.83
(9) Peters, J. ; Blechert, S. Synlett 1997, 348.
(10) Collington, E. W.; Meyers A. I. J. Org. Chem. 1971, 36, 3044.
(11) Krapcho, P. A.; Glynn, G. A.; Grenon, B. J. Tetrahedron Lett.
1967, 3, 215.
(12) Knerr, L.; Schmidt, R. R. unpublished results.
(13) Lay, L.; Windmüller, R. ; Reinhardt, S.; Schmidt, R. R.
Carbohydr. Res. 1997, 303, 39.
(14) Protocol for solid phase glycosylation: to deacetylated resin
9 (0.052 mmol) was added 11 (275 mg, 0.26 mmol, 5 eq.) in 5
ml CH2Cl2. The mixture was shaken 15min under argon.
TMSOTf (0.25 M in CH2Cl2, 50ml, 0.0125 mmol, 0.24 eq.)
was then added and the mixture was shaken 1h at r.t. under
argon. The resin was filtered and washed four times each with
5 ml of THF and 5 ml of CH2Cl2. After extensive drying under
high vacuum the resin was glycosylated a second time (1.7 eq.
11, 0.1 eq. TMSOTf) to ensure a complete reaction.
[CH2CH=CH2], 6.90-8.0 [6CH2Ph, 5COPh].
13a (selected data): 1H NMR (600 MHz, CDCl3): d 1.57
[C(CH3)2], 3.84 [CHHCH=CH2], 3.95 [CHHCH=CH2], 4.07
(1b-H), 4.54 (1d-H), 4.61 (1a-H, J1,2 = 3Hz), 5.00 (1c-H), 5.09
[CH2CH=CHH], 5.19 [CH2CH=CHH], 5.81 [CH2CH=CH2].
Article Identifier:
1437-2096,E;1999,0,11,1802,1804,ftx,en;G19099ST.pdf
Synlett 1999, No. 11, 1802–1804 ISSN 0936-5214 © Thieme Stuttgart · New York